NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: I. Background and Rationale

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 34, Issue 8, 1995, Pages 987-1000

  RICHTERS, JOHN E ^a   ARNOLD, L EUGENE ^a   JENSEN, PETER S ^a   ABIKOFF, HOWARD ^a   CONNERS, C KEITH ^a   GREENHILL, LAURENCE L ^a   HECHTMAN, LILY ^a   HINSHAW, STEPHEN P ^a   PELHAM, WILLIAM E ^a   SWANSON, JAMES M ^a  

^a NONE

Author keywords

attention deficit hyperactivity disorder; childhood disorders; multimodal treatment; psychopharmacological treatment; psychosocial treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CLONIDINE; DEXAMPHETAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PEMOLINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; FAMILY; GENDER; GROWTH RETARDATION; HOME; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MINIMAL BRAIN DYSFUNCTION; MORBIDITY; MULTICENTER STUDY; NUTRITIONAL STATUS; PRIORITY JOURNAL; SOCIAL INTERACTION;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMAN; MULTICENTER STUDIES; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 0029023201     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199508000-00008     Document Type: Article

References (153)

1. An evaluation of cognitive behavior therapy for hyperactive children
2. Interaction of methylphenidate and multimodal therapy in the treatment of attention-deficit hyperactivity disorder
3. Cognitive training in ademically deficient ADHD boys receiving stimulant medication
4. Does behavior therapy normalize the classroom behavior of hyperactive children?
5. Hyperactive children treated with stimulants: is cognitive training a useful adjunct?
6. The normalizing effects of methylphenidate on the classroom behavior of hyperactive children
7. Classroom observation code for hyperactive children: a replication of validity
8. Attention-deficit hyperactivity and conduct disorder: comorbidity and implications for treatment
9. Depressive realism: four theoretical perspectives
10. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children
11. Pharmacological intervention
12. DSM-III disorders in preadolescent children: prevalence in a large sample from the general population
13. Cognitive and social correlates of DSM-III disorders in preadolescent children
14. Diet and hyperkinesis
15. Prevention by specific perceptual remediation for vulnerable first-graders: controlled study and follow-up of lasting effects
16. Methylphenidate vs. dextroamphetamine vs. caffeine in minimal brain dysfunction
17. Vestibular visual rotational stimulation as treatment for attention deficit and hyperactivity
18. Differential effect of amphetamine optical isomers on Bender-Gestalt performance of the minimally brain dysfunctioned
19. Levoamphetamine vs. dextroamphetamine in minimal brain dysfunction: replication and differential effect by diagnostic group and family rating
20. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo controlled comparison to d-amphetamine
21. Does hair zinc predict amphetamine improvement of ADHD/hyperactivity?
22. A review of stimulant drug research with hyperactive children
23. A self-control classroom for hyperactive children
24. Do stimulant drugs improve the academic performance of hyperkinetic children?
25. The effects of methylphenidate on the mother-child interactions of hyperactive children
26. The adolescent outcome of hyperactive children diagnosed by research criteria: an 8-year prospective follow-up
27. Tactile-sensitive behavior in hyperactive and nonhyperactive children
28. A survey study of the use of electropupillogram in predicting response to psychostimulants
29. Hyperkinesis treated by vestibular stimulation: an exploratory study
30. A double-blind placebo controlled study of desipramine on the treatment of ADD: II. Serum drug levels and cardiovascular findings
31. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders
32. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico
33. Hyperactive boys and their brothers: a follow-up study
34. Hyperkinesis: prevalence and treatment
35. Correlates and predictors of hyperactivity and aggression: a longitudinal study of parent-referred problem preschoolers
36. A four-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children
37. Optimal dosages of methylphenidate for improving the learning and behavior of hyperactive children
38. Short-term variations in diet composition change the patterns of spontaneous motor activity in rats
39. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: a double-blind crossover comparison with methylphenidate
40. The effects of methylphenidate on symptomatology and learning in disturbed children
41. Effects of methylphenidate on paired associate learning and Porteus maze performance in emotionally disturbed children
42. Pharmacotherapy
43. Genetic latent structure analysis of dysmorphology and attention deficit disorder
44. Dosage effects and individual responsivity to methylphenidate in attention-deficit hyperactivity disorder
45. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
46. Differential effects of parent training and stimulant medication with hyperactives
47. Hyperactive behavior and minor physical anomolies
48. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings
49. Dosage effects of methylphenidate on paired-associate learning: positive/negative placebo responders
50. A controlled trial of behavior modification and methylphenidate in hyperactive children
51. Hyperactive boys almost grown up: I. Psychiatric status
52. Comparative effects of methylphenidate and thioridazine in hyperkinetic children: I. Clinical results
53. Normative data on revised Conners Parent and Teacher Rating Scales
54. Stimulant-related growth inhibition in children: a review
55. Pharmacotherapy: stimulants
56. Growth hormone, prolactin, and growth responses in hyperkinetic males treated with d-amphetamine
57. Prolactin, growth hormone, and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate
58. Specificity of inattention, impulsitivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder
59. Adverse side effects among mentally retarded children with ADHD
60. Aims and methodological problems in multimodal treatment studies
61. Hyperactives as young adults: initial predictors of adult outcome
62. Hyperactive children in adulthood: a controlled prospective ten-year follow-up
63. On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in child psychopathology
64. Stimulant medication and the treatment of aggression in children with attentional deficits
65. Externalizing behavior problems and academic under-achievement in childhood and adolescence: causal relationships and underlying mechanisms
66. Anger control in response to verbal provocation: effects of stimulant medication for boys with ADHD
67. Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate
68. Cognitive-behavioral and pharmacological intervention for hyperactive boys: comparative and combined effects
69. Self-control in hyperactive boys in anger-inducing situations: effects of cognitive-behavioral training and of methylphenidate
70. Psychotherapy and drug therapy: comparisons and combinations
71. Additive effects of Dexedrine and self-control training: a multiple assessment
72. Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children
73. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review
74. Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report
75. Long-term outcome of hyperactive children: a review
76. Clinical effects of a controlled trial of methylphenidate on adolescents with ADD
77. Ritalin blood levels and their correlation with measures of learning
78. The hyperkinetic child grows up: predictors of symptoms, delinquency and achievements at follow-up
79. Hyperactivity, inattention, and aggression in clinical practice
80. Hyperactive boys and their brothers at 21: predictors of aggressive and antisocial outcomes
81. Hyperactive boys almost grown up: V. Replication of psychiatric status
82. Hyperactive children as teenagers: a follow-up study
83. Socialization and peer relations in the hyperactive child
84. Amino acid supplementation as therapy for attention deficit disorder (ADD)
85. Defined diets and childhood hyperactivity
86. The emergence of attention deficits in early childhood: a prospective study
87. Peer relationships in hyperactive children: description and treatment
88. Methylphenidate and children with attention deficit disorder: dose effects on classroom academic and social behavior
89. Relative efficacy of long-acting stimulants on children with attention-deficit hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline
90. Behavioral assessment of psychostimulant effects on ADD children in a summer day treatment program
91. Behavioral and pharmacological treatment of hyperactivity and attention-deficit disorders
92. Methylphenidate and attributions in boys with ADHD
93. Correlates of pharmaco-kinetics and attentional measures in methylphenidate treated hyperactive children
94. Effect of anxiety on cognition, behavior, and stimulant response in ADHD
95. Iron deficiency and behavioral development in infants and preschool children
96. Behavioral effects of iron deficiency anemia in children
97. Disorders usually first evident in infancy, childhood, or adolescence
98. A one year follow-up of hyperactive boys treated with imipramine or methylphenidate
99. An open trial of l-tyrosine in the treatment of attention-deficit hyperactivity disorder, residual type
100. Effects of methylphenidate dosage in hyperactive reading-disabled children: II. Reading achievement
101. Mark Twain meets DSM-III-R: conduct disorder, development, and the concept of harmful dysfunction
102. Reactive attachment disorder of infancy or early childhood
103. A two year follow-up of 72 hyperactive boys
104. Syndromes attributed to minimal brain dysfunction in childhood
105. Psychological therapies in child psychiatry: issues and prospects
106. A survey of medication treatment for hyperactive/inattentive students
107. Pathophysiology of the hyperactive child syndrome
108. Multimodality treatment: a one-year follow-up of 84 hyperactive boys
109. Three-year multimodality treatment study of 100 hyperactive boys
110. Therapeutic interventions to prevent delinquency in hyperactive boys
111. Childhood hyperactivity and psychostimulants: a review of extended treatment studies
112. Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample
113. A critical note on the predictive validity of the hyperkinetic syndrome
114. Prescribing practices of Ritalin: the Suffolk County, New York study
115. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior
116. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders
117. Learning in hyperactive children: are there stimulant-related and state-dependent effects?
118. The state-dependent and main effects of pemoline and methylphenidate on paired-associate learning and spelling in hyperactive children
119. Paired associate learning in the assessment of ADDH children
120. Stimulant-related state dependent learning in hyperactive children
121. The cognitive effects of stimulant drugs on hyperactive (inattentive) children
122. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity
123. Childhood hyperactivity
124. Evidence for an independent syndrome of hyperactivity
125. Intraindividual comparison of 21-day application of amphetamine and methylphenidate in hyperkinetic children
126. The effects of methylphenidate on learning in children with ADDH: the stimulus equivalence paradigin
127. Studies on the hyperactive child: VIII. Five-year follow-up
128. Haloperidol and methylphenidate in hyperactive children
129. Behavior observations of hyperactive children and methylphenidate (Ritalin) effects in systematically structured classroom environments: now you see them, now you don't
130. Docs stimulant medication improve the peer status of hyperactive children?
131. Peer interaction in a structured communication task: comparisons of normal and hyperactive boys and of methylphenidate (Ritalin) and placebo effects
132. Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children
133. Stimulants, urinary catecholamines, and indoleamines in hyperactivity
134. The pathophysiology of attention deficit disorder with hyperactivity